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Abstract
Viral infections are common clinical problems in aged individuals often affecting both mortality and morbidity. The
pathogenic mechanisms of the various viruses are not universal in aged individuals, i.e. the clinical disease may be
caused by the reactivation of a virus which has stayed in the body in a latent form, or alternatively, the virus is
exogenous, derived from the environment. However, it is now evident, that this concept is too simple. Recent data
have shown that in our body, even in the blood of healthy individuals, there are large amount of various viruses,
which seem to live in balance with our immune defense mechanism (viral normal flora?). Moreover, there is now
data suggesting that remnants of ancient retroviral infections in our genome can be activated and show virus-like
activities. The possible significance of these findings in immunosenescence is discussed.
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Introduction
Our body is in continuous contact with viruses and vari-
ous defense mechanisms are used to prevent the entry
or to eliminate the invader within the body. There is
ample evidence demonstrating that the aging-associated
decline of the immune system, i.e. immunosenescence,
significantly weakens these mechanisms [1]. This is often
observed in the case of common viral pathogens, e.g.
influenzavirus [2]. On the other hand, it is known that at
least some viruses may induce or modify immunosenes-
cence and in this respect cytomegalovirus (CMV) is the
classical and extensively investigated example [3]. How-
ever, there is now emerging evidence showing that the
number of viruses or virus-like entities is much larger
than expected i) next generation (NGS) RNA/DNA
sequencing based approaches have shown that within
our body there are large amounts of various viruses even
without known clinical or biological significance (form-
ing the virome) [4], i.e. the classical concept about the
“sterility” of the inner body should be rejected ii) our
genome contains mobile genetic elements (retrotranspo-
sons, endogeneous retroviruses (HERV), some of which
may still be active and might modify the immune system
[5]. In this review, these two concepts are briefly
described and their role in immunosenescence is
discussed.
More viral candidates
The human body contains microbial communities (bac-
teria. fungi, viruses and protozoa) in its various compart-
ments, often called the local microbiome (e.g. gut
microbiome) and this can be further specified by the
type of the microbe (e.g. gut virome). In traditional
clinical microbiology changes in the composition of
these microbiomes is analyzed in a simple and limited
way, i.e. by searching known pathogenic microbes within
these populations. However, during recent years the
NGS –based analyses of all the DNA/RNA in the sample
(i.e. metagenomic and metatranscriptomic analysis) and
advances in bioinformatics have allowed the detection of
all or at least most of the microbes in a given microbiome.
The results have been surprising. Changes in the
microbiome (mainly gut bacteriome) have been observed
to be associated with several environmental and life-
style factors, aging, and with several disease states [6, 7].
These observations have been associative, i.e. the causal
relationship e.g. with a given molecular activation path-
way or with the pathogenic mechanisms in diseases have
remained enigmatic. However, it is very likely that the
effects of microbiome on human health starts already in
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childhood maybe having a role in the development and
physiology of the body.
Analysis of the virome (including bacteriophages) is
technically more challenging than that of the bacter-
iome. Viruses lack a clear sequence signatures (in
contrast to bacteria) and therefore sequencing of large
viral libraries is time-consuming and not easily applic-
able to a simultaneous analysis of large number of
samples.
The first virome analyses have now been published [4].
It seems that the different compartments of the body
harbor distinct viral communities. However, the total
number of viruses is highly variable, 109 particles per
gram in the intestinal content, 107/ml in the urine and
105 /ml in the blood. Studies on gut virome have shown,
that the most common viruses are not those infecting
eukaryotic cells, but those infecting prokaryotic cells,
bacteriophages, form a clear majority [8]. It has even
been estimated that bacteriophages outnumber all forms
of life on our planet [9].
The presence of phages was demonstrated about 100
years ago, and their life-cycle within the bacteria as well
as their role in modulating the functions of bacteria, e.g.
mediating toxin production or antibiotic resistance are
all well known [10]. Moreover, based on their bacteri-
cidal effect, phages have been attractive candidates for
anti-microbial therapy in humans.
This far the relationship between virome composition
and immunosenescence is not known. However, there
are several reports demonstrating changes in the gut
virome compostion in diseases of immunological nature,
e.g. type I diabetes [11]. Moreover, in immunocomprom-
ised patients (DOCK8 deficiency) the skin virome is
clearly expanded [12]. Based on these, it could be ex-
pected that immunosenescence would have an influence
on virome composition. However, its possible role in the
aging-associated pathologies can presently only be spec-
ulated. Does the weaker immunity allow the presence of
potentially pathogenic viruses in the blood of elderly in-
dividuals? It is also possible that this viral “normal flora”
would have a protective effect, in analogy with the
bacterial normal flora in several compartments of the
human body.
An interesting question is also the role of bacterio-
phages. Aging is associated with changes in the gut
bacteriome [13]. As bacteriophages are derived from the
gut bacteria, it is probable that the phageome compos-
ition is also changed in aged individuals. It has been
shown that some bacteriophages are able to induce the
production of inflammatory cytokines in vitro [14]. As
leakage of the gut is increased in aged individuals, it
seems possible that this increased amount of proinflam-
matory bacteriophages or other viruses would contribute
to inflammaging.
Finally, a common feature in these metagenomic
analyses has been the high proportion of “dark matter”,
i.e. sequences that do not align with the sequences of
the reference human genome or those of known viruses
or bacteria. It is probably at least partly caused by
difficulties in the bioinformatics analyses, but it may also
contain sequences of presently unknown viruses. Still
more players in the field?
Ancient invaders
About a half of the human genome is derived from
mobile genomic elements. These elements can be
categorized as transposons and retrotransposons, which
differ in their mechanism of action. Transposons move
by a “cut-and-paste” mechanism while retrotransposons
use an RNA intermediate, i.e. a “copy-and-paste” mech-
anism. Retrotransposons can further be subdivided into
long terminal repeat (LTR) and non-LTR elements.
Human endogenous retroviruses (HERV) belong to the
LTR subset. They comprise ca. 8% of the human gen-
ome, i.e. a significant proportion of our genome is de-
rived from invasions by exogenous retroviruses during
evolution [5, 15].
There is now increasing evidence that both the non-
LTR and LTR retrotransposons are involved in the aging
process. LINE-1, the main component of the non-LTR
group (ca. 17% of the human genome), is the only active
retrotransposon in the human body, and its insertional
polymorphisms in the germline DNA are associated with
several diseases, e.g. hemophilia [16]. This far there is no
evidence showing associations between these genetic
polymorphisms with the aging process or longevity in
humans. However, as LINE-1 is continuously active it is
possible that it induces somatic mutations during
lifetime in this way modifying the aging process. The
indications of the aging-associated increase in LINE-1
retrotransposonal activity are the increases in its copy
number in the genome as well as in its RNA levels [17].
Although this LINE-1 –induced somatic retrotransposo-
nal acivity is an attractive model, firm evidence of its
functionality in the aging process is still missing. How-
ever, it is also possible that aging-associated increase in
LINE-1 expression has an effect on aging associated
inflammation via a different mechanism. De Cecco et al.
[18] demonstrated that LINE-1 activity was clearly in-
creased in the proinflammatory senescent associated
secretory phenotype cells and activated the interferon –
dependent classical anti-viral mechanism cGAS-STING,
i.e. behaving like a virus.
As mentioned above, HERVs are relics of ancient
retroviral infections in our genome comprising ca. 8% of
our genome. They have lost their infective/retrotranspo-
sonal activity due to recombinations, deletions, and
mutations during their millions years of history [5, 15].
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HERVs have been shown to be involved in the pathogen-
esis of autoimmune diseases, activation of B cells and T
regulatory cells and in malignant transformation [19],
but the exact mechanisms of action are still elusive.
Several of these studies are compromised by the fact that
there are thousands of HERVs demonstrating different
biological activities (or are totally inactive due to the lack
of production of the HERV proteins, env, gag and pol).
Also in this case the NGS RNA sequencing has provided
a technical solution, i.e. allowing the determination of
expression levels of all the individual proviruses if the
genetic annotation data are available. Using this ap-
proach Nevalainen et al. [20] examined the expression of
the proviruses in the HERV-K (HML-2) family. This
family is the most recent entrant to our genome there-
fore containing several intact proviruses [21]. Out of the
91 proviruses circa one third was clearly expressed and
this expression was significantly higher in elderly indi-
viduals in the case of only two proviruses (at 1q22 and
at 10p14). It is unlikely that the weaker immune capacity
would be responsible for these differences, but it is more
probably due to the aging-associated decline of the
epigenetic control [22]. The functional consequences of
this increased expression are not yet clear. It is naturally
possible that the retroviral DNA/RNA is recognized by
the interferon-mediated anti-viral mechanisms in this
way stimulating the inflammatory response, i.e. in a
similar way as observed in the case of LINE-1. This
would mean that the effect of HERVs is non-specific, de-
pending simply on the total quantity of the DNA/RNA
stimulus. However, it is obvious that the HERV encoded
proteins (e.g. env) can be recognized by the immune
system and such antibodies (autoantibodies?) can be de-
tected in several disease states [5] but their functional
significance is still largely unknown. There is one study
showing that the titer of these antibodies is affected by
aging, i.e. immunosenescence [23]. Moreover, already
several years ago it was demonstrated that at least one
HERV-K encoded env acts as a superantigen, i.e. causing
a polyclonal activation of lymphocytes [24]. Maybe this
superantigenic capacity, if it is a common character of
several proviruses, is also involved in the exhaustion and
deterioration of the immune system during aging.
Conclusions
The data shown here indicate that the relationship
between viruses, virosphere, and immunosenescence is
more complex than previously thought. Firstly, the
expressions of the repetitive elements in our genome
(HERV, LINE-1) are able to activate immune/inflamma-
tory responses in this way modulating the development
of immunosenescence. Secondly, it is now evident that
large amounts of viruses can be detected in our inner
body, e.g. in the blood, which has previously thought to
be sterile in healthy individuals. The origin of this
virome, its pathogenic significance as well as the effect
of immunosenescence on its composition are not yet
known. The tentative role of these virus-mediated effects
in immunosenescence is schematically shown in the
figure below (Fig. 1).
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